Oxidized carbon nanoparticles as an effective protein antigen delivery system targeting the cell-mediated immune response

References

• Kim BYS, Rutka JT, Chan WCW. Nanomedicine. New Engl J Med. 2010;363(25):2434–2443. doi:10.1056/NEJMoa101120521158659
   PubMed Web of Science ®Google Scholar
• Clark TG, Cassidy-Hanley D. Recombinant subunit vaccines: potentials and constraints. Dev Biol (Basel). 2005;121:153–163.15962478
   PubMedGoogle Scholar
• Zhao L, Seth A, Wibowo N, et al. Nanoparticle vaccines. Vaccine. 2014;32(3):327–337. doi:10.1016/j.vaccine.2013.11.06924295808
   PubMed Web of Science ®Google Scholar
• Black M, Trent A, Tirrell M, Olive C. Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists. Expert Rev Vaccines. 2010;9(2):157–173. doi:10.1586/erv.09.16020109027
   PubMed Web of Science ®Google Scholar
• Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010;10:787. doi:10.1038/nri286820948547
   PubMed Web of Science ®Google Scholar
• Irvine DJ, Hanson MC, Rakhra K, Tokatlian T. Synthetic nanoparticles for vaccines and immunotherapy. Chem Rev. 2015;115(19):11109–11146. doi:10.1021/cr500441926154342
   PubMed Web of Science ®Google Scholar
• Arayachukeat S, Palaga T, Wanichwecharungruang SP. Clusters of carbon nanospheres derived from graphene oxide. ACS Appl Mater Interfaces. 2012;4(12):6808–6815. doi:10.1021/am301240623182150
   PubMedGoogle Scholar
• Arayachukiat S, Seemork J, Pan-In P, et al. Bringing macromolecules into cells and evading endosomes by oxidized carbon nanoparticles. Nano Lett. 2015;15(5):3370–3376. doi:10.1021/nl504066f25849219
   PubMedGoogle Scholar
• Amornwachirabodee K, Tantimekin N, Pan-In P, et al. Oxidized carbon black: preparation, characterization and application in antibody delivery across cell membrane. Sci Rep. 2018;8(1):2489. doi:10.1038/s41598-018-20650-429410523
   PubMedGoogle Scholar
• Amornwachirabodee K, Khramchantuk S, Pienpinijtham P, Israsena N, Palaga T, Wanichwecharungruang S. Enhancing passive transport of micro/nano particles into cells by oxidized carbon black. ACS Omega. 2018;3(6):6833–6840. doi:10.1021/acsomega.8b0048730023963
   PubMedGoogle Scholar
• Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958. doi:10.1038/nri244819029990
   PubMed Web of Science ®Google Scholar
• Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011;11:762. doi:10.1038/nri307021984070
   PubMed Web of Science ®Google Scholar
• Itano AA, Jenkins MK. Antigen presentation to naive CD4 T cells in the lymph node. Nat Immunol. 2003;4:733. doi:10.1038/ni95712888794
   PubMed Web of Science ®Google Scholar
• König R, Huang L-Y, Germain RN. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature. 1992;356:796. doi:10.1038/356796a01574118
   PubMed Web of Science ®Google Scholar
• Kasturi SP, Pulendran B. Cross-presentation: avoiding trafficking chaos? Nat Immunol. 2008;9:461.18425099
   PubMed Web of Science ®Google Scholar
• Fehres CM, Unger WWJ, Garcia-Vallejo JJ, van Kooyk Y. Understanding the biology of antigen cross-presentation for the design of vaccines against cancer. Front Immunol. 2014;5(149). doi:10.3389/fimmu.2014.00149
   PubMedGoogle Scholar
• Boonyatecha N, Sangphech N, Wongchana W, Kueanjinda P, Palaga T. Involvement of notch signaling pathway in regulating IL-12 expression via c-Rel in activated macrophages. Mol Immunol. 2012;51(3–4):255–262. doi:10.1016/j.molimm.2012.03.01722463790
   PubMedGoogle Scholar
• Sawutdeechaikul P, Cia F, Bancroft G, Wanichwecharungruang S, Sittplangkoon C, Palaga T. Oxidized carbon nanosphere-based subunit vaccine delivery system elicited robust Th1 and cytotoxic T cell responses. J Microbiol Biotechnol. 2019;29(3):489–499. doi:10.4014/jmb.1810.1005330691253
   PubMedGoogle Scholar
• Saraste J, Palade GE, Farquhar MG. Temperature-sensitive steps in the transport of secretory proteins through the Golgi complex in exocrine pancreatic cells. Proc Natl Acad Sci U S A. 1986;83(17):6425–6429. doi:10.1073/pnas.83.17.64253462704
   PubMedGoogle Scholar
• dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One. 2011;6(9):e24438. doi:10.1371/journal.pone.002443821949717
   PubMed Web of Science ®Google Scholar
• Kuhn DA, Vanhecke D, Michen B, et al. Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein J Nanotechnol. 2014;5:1625–1636. doi:10.3762/bjnano.5.17425383275
   PubMed Web of Science ®Google Scholar
• Dutta D, Donaldson JG. Search for inhibitors of endocytosis: intended specificity and unintended consequences. Cell Logist. 2012;2(4):203–208. doi:10.4161/cl.2396723538558
   PubMedGoogle Scholar
• Kanlaya R, Sintiprungrat K, Chaiyarit S, Thongboonkerd V. Macropinocytosis is the major mechanism for endocytosis of calcium oxalate crystals into renal tubular cells. Cell Biochem Biophys. 2013;67(3):1171–1179. doi:10.1007/s12013-013-9630-823695784
   PubMedGoogle Scholar
• Sandvig K, Kavaliauskiene S, Skotland T. Clathrin-independent endocytosis: an increasing degree of complexity. Histochem Cell Biol. 2018;150(2):107–118. doi:10.1007/s00418-018-1678-529774430
   PubMed Web of Science ®Google Scholar
• Gustafson HH, Holt-Casper D, Grainger DW, Ghandehari H. Nanoparticle uptake: the phagocyte problem. Nano Today. 2015;10(4):487–510. doi:10.1016/j.nantod.2015.06.00626640510
   PubMed Web of Science ®Google Scholar
• Adiko AC, Babdor J, Gutierrez-Martinez E, Guermonprez P, Saveanu L. Intracellular transport routes for MHC I and their relevance for antigen cross-presentation. Front Immunol. 2015;6:335. doi:10.3389/fimmu.2015.0033526191062
   PubMed Web of Science ®Google Scholar
• Silva JM, Vandermeulen G, Oliveira VG, et al. Development of functionalized nanoparticles for vaccine delivery to dendritic cells: a mechanistic approach. Nanomedicine (Lond). 2014;9(17):2639–2656. doi:10.2217/nnm.14.13525529568
   PubMedGoogle Scholar
• Longhi MP, Trumpfheller C, Idoyaga J, et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med. 2009;206(7):1589–1602. doi:10.1084/jem.2009024719564349
   PubMed Web of Science ®Google Scholar
• Gnjatic S, Sawhney NB, Bhardwaj N. Toll-like receptor agonists: are they good adjuvants? Cancer J. 2010;16(4):382–391. doi:10.1097/PPO.0b013e3181eaca6520693851
   PubMed Web of Science ®Google Scholar
• Russell DG, Huang L, VanderVen BC. Immunometabolism at the interface between macrophages and pathogens. Nat Rev Immunol. 2019;19(5):291–304. doi:10.1038/s41577-019-0124-930679807
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805–820. doi:10.1016/j.cell.2010.01.02220303872
   PubMed Web of Science ®Google Scholar
• Nembrini C, Stano A, Dane KY, et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc Natl Acad Sci USA. 2011;108(44):E989–E997. doi:10.1073/pnas.110426410821969597
   PubMed Web of Science ®Google Scholar